Invention Grant
- Patent Title: Triazolo compounds useful as DGAT1 inhibitors
- Patent Title (中): 可用作DGAT1抑制剂的三唑类化合物
-
Application No.: US12936969Application Date: 2009-04-07
-
Publication No.: US08324241B2Publication Date: 2012-12-04
- Inventor: Yanting Huang , Chongqing Sun , R. Michael Lawrence , William R. Ewing , Huji Turdi
- Applicant: Yanting Huang , Chongqing Sun , R. Michael Lawrence , William R. Ewing , Huji Turdi
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Burton Rodney
- International Application: PCT/US2009/039770 WO 20090407
- International Announcement: WO2009/126624 WO 20091015
- Main IPC: C07D277/42
- IPC: C07D277/42 ; C07D487/04 ; C07D471/22 ; C07D471/14 ; A61K31/427 ; A61K31/437 ; A61K31/5025 ; A61P3/04 ; A61P3/10 ; A61P9/10
Abstract:
Disclosed are triazolopyridine compounds of Formula (I), including pharmaceutically acceptable salts thereof. Also, disclosed are methods of using the compound in the treatment of obesity, dyslipidemia, diabetes and atherosclerosis, and to pharmaceutical compositions comprising at least one compound of Formula (I) or a stereoisomer or pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20110034468A1 TRIAZOLO COMPOUNDS USEFUL AS DGAT1 INHIBITORS Public/Granted day:2011-02-10
Information query
